Angitia ends Phase 3 in disc disease; Abivax raises $800M on colitis data

July 1, 2026 09:29 AM EDT

News Briefing

An­gi­tia ends Phase 3 in disc dis­ease; Abi­vax rais­es $800M on col­i­tis da­ta

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Think we're worth reading - tell Google.